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Abstract
People withChagasdisease are at a higher risk of death due to cardiac arrest (CA). Considering thatChagasdisease remains a serious
health problem in Latin America, studies in this regard are still needed. The aim of this study was to present 2 patients with Chagas
that developed CA and were treated at the emergency department of a reference hospital in Brazil (Sao Paulo city). Case one: Male
(73 years old and Caucasian) with a history of systemic arterial hypertension, diabetes mellitus, liver cirrhosis, and Chagas disease
associated with megacolon and megaesophagus. After cardiac collapse and 30 minutes of cardiopulmonary resuscitation (CPR),
unfortunately the patient died. Case two: A female patient (64 years old and Caucasian), with a history of systemic arterial hyper-
tension, obesity, and Chagas disease. After 23 days of hospitalization, pharmacological therapy, and implantation of a cardioverter
defibrillator, the patient was discharged. People withChagasdisease are at a higher risk of CA. The researchers believe that a prompt
and efficient treatment (advanced life support) allied with educational programs on CA recognition targeted at health professionals
and caregivers (basic life support knowledge) could improve the prognoses of these patients.
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1. Introduction
Chagas disease is caused by the protozoan parasite Try-
panosoma cruzi. The main form of transmission occurs by
contact of damaged skin and mucous membranes with fe-
ces contaminated with insect vectors (1). The epidemiolog-
ical profile of the disease has changed due to urbanization
and globalization, and has currently placed non-endemic
countries at risk because of immigration of infected indi-
viduals to developed countries, mainly Europe and North
America (2, 3).
Approximately 95% of acute cases of Chagasdisease are
asymptomatic. The remaining symptomatic cases present
fever, malaise, muscle, joint pains, somnolence, cramps,
diarrhea, edema, respiratory disturbances, cyanosis, and
comma (4). Acute cases (with or without symptoms) of in-
fection lead to chronic illness, while 66% of people with
chronic infection do not show any detectable clinical man-
ifestation. However, 33% of the chronically infected human
population develops clinical manifestations of Chagas dis-
ease (4, 5). These chronic clinical manifestations affect the
heart in 94.5% of cases.
Previous studies have shown that patients with Cha-
gas disease are at a higher risk of death by sudden cardiac
death when compared with the general population (6, 7),
especially due to cardiac arrest (CA). Braggion-Santos et al.
(6) conducted a study that evaluated 4501 autopsies and
found that 5.5% (n = 49) of patients that suffered sudden
cardiac death had Chagas disease.
Considering that Chagas disease remains a serious
health problem in Latin America and others tropical re-
gions, it is important to investigate and report these cases.
The aim of this study was to present 2 patients with Cha-
gas diseases, which presented CA, and were treated at the
emergency department of a reference hospital in Brazil.
The patients were extracted from a sample of a prospective
study (performed from February 2011 to January 2012), pre-
viously published by the research group (8).
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2. Case Presentation
2.1. Case One
Male patient: (73-year-old and Caucasian) with a his-
tory of systemic arterial hypertension, diabetes mellitus,
liver cirrhosis, and Chagas disease associated with mega-
colon and megaesophagus. He used an enteric catheter
and was moderately dependent for daily-life activities and
was admitted to the emergency department presenting
breath discomfort and apathy. He was diagnosed with hy-
poactive delirium. After 5 days of hospitalization and treat-
ment with antibiotics, he experienced CA. The patient was
observed by a health team, who attributed the CA to res-
piratory insufficiency with initial asystole rhythm. Venti-
lations, external chest compressions, tracheal intubation,
multi-parametric monitoring, venous access puncture, ad-
ministration of epinephrine, and defibrillation were per-
formed. The time between cardiac collapse and onset
of cardiopulmonary resuscitation (CPR) maneuvers was
1 minute, the first shock was performed 4 minutes after
the cardiac collapse, tracheal intubation was performed
6 minutes after the cardiac collapse, and the first dose of
epinephrine was administered 1 minute after the cardiac
collapse; CPR lasted 30 minutes. The patient died due to
acute respiratory failure.
2.2. Case Two
Female patient: 64 years old and Caucasian with a his-
tory of systemic arterial hypertension, obesity, and Chagas
disease. Independent for daily-life activities. She was ad-
mitted to the emergency department due to fainting fol-
lowed by palpitations and was diagnosed with atrial fib-
rillation with high ventricular response and submitted to
synchronized electrical cardioversion. However, during
the procedure, the patient developed CA. Ventilation, ex-
ternal chest compressions, defibrillation, tracheal intuba-
tion, and multi-parametric monitoring were performed.
The time between cardiac collapse and onset of CPR ma-
neuvers was 2 minutes, the first shock was applied 5 min-
utes after cardiac collapse, and a tracheal intubation was
performed 7 minutes after cardiac collapse; the CPR lasted
7 minutes. The patient returned to spontaneous circu-
lation, and developed three more CA, all with an initial
rhythm of ventricular fibrillation, yet reverted after the
first shock. The diagnosis during 23 days of hospitalization
was cardiogenesis followed by septic shock. The patient
was treated with cardiotonic agents and antibiotics, and
was later discharged without neurological alterations, af-
ter an implantation of a cardioverter defibrillator.
3. Discussion
Chagasdisease is an infectious condition, which effects
approximately 6 to 7 million people worldwide. Most of
these cases live in Latin America (9). Heart is affected in
94.5% of symptomatic patients and these patients are con-
sidered to have chronic Chagas heart disease. Heart insuf-
ficiency is associated with the cause of death cause in 58%
of the patients, whereas arrhythmias have been associated
with unexpected deaths in 36.5% of the patients (particu-
larly due to CA). The other 4.5% of patients with chronic
Chagas infection show mega syndromes, especially in gas-
trointestinal tract, a disease state that involves the en-
largement of esophagus (mega-esophagus) and the colon
(megacolon) (4, 10).
Furthermore, CA could be defined as abrupt loss of
heart function in a person, who may or may not have been
diagnosed with heart disease (11, 12). Vancini-Campanharo
et al. (8) conducted a study to characterize patients, who
had suffered CA, and to identify factors related to their
mortality. In this study, 285 patients (66.3 ± 17.2 years)
were followed for 1 year after treatment for CA. Respira-
tory failure was the most common presumed immediate
cause of death (30.8%), while pulseless electrical activity
was the most frequent initial rhythm (58.7%). The authors
concluded that the mortality rate among CA patients was
high (95.4%) and that the variable that best explained mor-
tality was the initial CA rhythm.
Even though both patients presented alterations of
their initial cardiac rhythm only the male died. The re-
searchers believe that the female survived CA because she
was younger and had a better clinical condition than the
male patient (i.e. independence to perform daily-life activ-
ities).
The male subject presented diabetes mellitus, liver cir-
rhosis, megacolon, and megaesophagus. These clinical
conditions confirm a more deteriorated health. The diges-
tive form of Chagas disease, presented by the male, may
effect all organs in the gastrointestinal tract, especially
esophagus and large intestine resulting in megaesopha-
gus and megacolon, respectively. It is worth mentioning
that 65% of patients present megaesophagus, megacolon,
and heart disease, simultaneously.
The female patient presented atrial fibrillation. Atrial
fibrillation was the most frequently observed sustained
supraventricular arrhythmia in chronic manifestation of
Chagasdisease; it is found in 4% to 12% of cases (13). It tends
to manifests later on and is often associated with a marked
cardiomegaly.
Both patients presented alteration in ventricular func-
tion. Bestetti and Cardinalli-Neto (7) pointed that patients
with Chagas disease and ventricular tachyarrhythmias are
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at a higher risk of sudden cardiac death. These patients
should undergo primary and secondary prevention pro-
grams, such as programmed ventricular stimulation, im-
plantable cardioverter defibrillator, amiodarone therapy,
and catheter ablation.
Despite of the decrease in infected people and death
cases, Chagas disease is still prevalent in Latin America;
the disease morbidity and mortality is still higher than
it should be. Unfortunately, Chagas continues to be rela-
tively ignored by the society and it is generally neglected by
government authorities. Governments, especially in Latin
America, need to give higher priority to this health issue.
It is also necessary to mobilize resources and capabilities
from different society sectors, such as non-governmental
and private organizations to combat and prevent this dis-
ease (14).
In addition, educational programs for CA recognition
(despite that the frequency of treated and attended pa-
tients, at an emergency department, have been low) tar-
geted at health professionals and caregivers could improve
the prognoses of individuals already infected with Chagas
disease. It is also advisable to educate the general public
on CA recognition since this knowledge may increase the
chances of survival before the arrival of advanced life sup-
port.
Footnote
Financial Disclosure: The authors report no real or per-
ceived vested interests that are related to this article that
could be construed as a conflict of interest.
References
1. Rassi AJ, Rassi A, Marin-Neto JA. Chagas disease. Lancet.
2010;375(9723):1388–402. doi: 10.1016/S0140-6736(10)60061-X.
[PubMed: 20399979].
2. Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL, Council on
Chagas Disease of the Interamerican Society of C. Chagas disease: an
overview of clinical and epidemiological aspects. J Am Coll Cardiol.
2013;62(9):767–76. doi: 10.1016/j.jacc.2013.05.046. [PubMed: 23770163].
3. Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO. Diagnosis and
management of Chagas disease and cardiomyopathy. Nat Rev Car-
diol. 2012;9(10):576–89. doi: 10.1038/nrcardio.2012.109. [PubMed:
22847166].
4. Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA.
Chagas disease. Postgrad Med J. 2006;82(974):788–98. doi:
10.1136/pgmj.2006.047357. [PubMed: 17148699].
5. Prata A. Chagas’ disease. Infect Dis Clin North Am. 1994;8(1):61–76.
[PubMed: 8021449].
6. Braggion-Santos MF, Volpe GJ, Pazin-Filho A, Maciel BC, Marin-Neto
JA, Schmidt A. Sudden cardiac death in Brazil: a community-based
autopsy series (2006-2010). Arq Bras Cardiol. 2015;104(2):120–7. doi:
10.5935/abc.20140178. [PubMed: 25424162].
7. Bestetti RB, Cardinalli-Neto A. Sudden cardiac death in Chagas’ heart
disease in the contemporary era. Int J Cardiol. 2008;131(1):9–17. doi:
10.1016/j.ijcard.2008.05.024. [PubMed: 18692919].
8. Vancini-Campanharo CR, Vancini RL, de Lira CA, Andrade MD, Lopes
MC, Okuno MF, et al. Characterization of cardiac arrest in the
emergency department of a Brazilian University Reference Hospi-
tal: A prospective study. Indian J Med Res. 2016;144(4):552–9. doi:
10.4103/0971-5916.200898. [PubMed: 28256463].
9. World Health Organization (WHO) . Chagas disease (American try-
panosomiasis) Geneva: World Health Organization; 2015. Available
from: http://www.who.int/mediacentre/factsheets/fs340/en/.
10. Meneghelli UG, de Godoy RA, Macedo JF, de Oliveira RB, Troncon LE,
Dantas RO. Basal motility of dilated and non-dilated sigmoid colon
and rectum in Chagas’ disease. Arq Gastroenterol. 1982;19(3):127–32.
[PubMed: 6821025].
11. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB,
et al. Heart disease and stroke statistics–2013 update: a report from
the American Heart Association. Circulation. 2013;127(1):e6–e245. doi:
10.1161/CIR.0b013e31828124ad. [PubMed: 23239837].
12. Berg RA, Hemphill R, Abella BS, Aufderheide TP, Cave DM, Hazinski MF,
et al. Part 5: adult basic life support: 2010 American Heart Associa-
tion Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2010;122(18 Suppl 3):S685–705. doi:
10.1161/CIRCULATIONAHA.110.970939. [PubMed: 20956221].
13. Garzon SA, Lorga AM, Nicolau JC. Electrocardiography in Chagas’
heart disease. Sao Paulo Med J. 1995;113(2):802–13. doi: 10.1590/S1516-
31801995000200011. [PubMed: 8650480].
14. Dias JC, Ramos AJ, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura
JR, et al. 2 nd Brazilian Consensus on Chagas Disease, 2015.Rev Soc Bras
Med Trop. 2016;49Suppl 1(Suppl 1):3–60. doi: 10.1590/0037-8682-0505-
2016. [PubMed: 27982292].
Arch Clin Infect Dis. 2017; 12(3):e12504. 3
